Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).
Avedissian SN, Rhodes NJ, Liu J, Aljefri D, Postelnick MJ, Sutton SH, Zembower TR, Martin D, Pais G, Cruce CE, Scheetz MH. Avedissian SN, et al. Among authors: aljefri d. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e01780-18. doi: 10.1128/AAC.01780-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30602510 Free PMC article.
Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections.
Elliott G, Malczynski M, Barr VO, Aljefri D, Martin D, Sutton S, Zembower TR, Postelnick M, Qi C. Elliott G, et al. Among authors: aljefri d. BMC Infect Dis. 2019 Nov 7;19(1):942. doi: 10.1186/s12879-019-4591-1. BMC Infect Dis. 2019. PMID: 31699044 Free PMC article.
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study.
Almangour TA, Ghonem L, Alassiri D, Aljurbua A, Al Musawa M, Alharbi A, Almohaizeie A, Almuhisen S, Alghaith J, Damfu N, Aljefri D, Alfahad W, Khormi Y, Alanazi MQ, Alsowaida YS. Almangour TA, et al. Among authors: aljefri d. Antimicrob Agents Chemother. 2023 Aug 17;67(8):e0040523. doi: 10.1128/aac.00405-23. Epub 2023 Jul 5. Antimicrob Agents Chemother. 2023. PMID: 37404159 Free PMC article.
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence.
Mohzari YA, Alamer A, Alattas M, Alrashed AA, Alshehab NA, Alkhaldi TK, Alamer AA, Asdaq SMB, Aljefri D, Alajami HN, Alsowaida YS, Mathew M, AlMusawa MI, Alomar M, Alharbi RY, Khuwaja M, Bamogaddam RF, Alharthi AH, Faqihi AY, Alrumayyan BF, Alshareef A, Alhassan BM, Damfu NY, Alajmi GS, Albujaidy A, Alghalbi M, Alajlan SA, Abraham I, Almulhim AS. Mohzari YA, et al. Among authors: aljefri d. Expert Rev Anti Infect Ther. 2022 Jul;20(7):1037-1047. doi: 10.1080/14787210.2022.2046462. Epub 2022 Mar 7. Expert Rev Anti Infect Ther. 2022. PMID: 35209783 Free PMC article.
Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study.
Almangour TA, Ghonem L, Alassiri D, Aljurbua A, Al Musawa M, Alharbi A, Almuhisen S, Alghaith J, Damfu N, Aljefri D, Alfahad W, Alrasheed M, Khormi Y, Almohaizeie A. Almangour TA, et al. Among authors: aljefri d. J Infect Chemother. 2024 Mar 25:S1341-321X(24)00099-0. doi: 10.1016/j.jiac.2024.03.015. Online ahead of print. J Infect Chemother. 2024. PMID: 38537776
Infectious diseases pharmacy practice, education, and research in Saudi Arabia: A review and future perspectives by the Infectious Diseases Pharmacy Specialty Network at the Saudi Society of Clinical Pharmacy.
Alsowaida YS, Thabit AK, Almangour TA, Bin Saleh K, Mahrous A, Saeed Almutairi M, Alshehail B, Aljefri D, Mohzari Y, Alfahad W, Almohaizeie A, Eljaaly K. Alsowaida YS, et al. Among authors: aljefri d. Saudi Pharm J. 2022 Dec;30(12):1836-1843. doi: 10.1016/j.jsps.2022.10.014. Epub 2022 Nov 3. Saudi Pharm J. 2022. PMID: 36601505 Free PMC article. Review.